Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

4DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ensereptide [inn], Unii-smv73kw49c, Smv73kw49c, Acetyl(human lactotransferrin-(15-39)-peptidamide), Chembl1213249, 254433-51-7

Molecular Formula

C₁₃₂H₂₁₇N₄₅O₃₃S₃

Molecular Weight

3058.6 g/mol

InChI Key

RGOYAPXMTXPMMR-VCYGAANBSA-N

1 2D Structure

Ensereptide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4S)-4-acetamido-5-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[[(3S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,45R,50R,53S,56S,59S)-50-[[(2S,3S)-1-[[(2S)-6-amino-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]-18-(4-aminobutyl)-27-(2-amino-2-oxoethyl)-33,39-bis(3-amino-3-oxopropyl)-42-benzyl-12,21,30-tris(3-carbamimidamidopropyl)-53-(hydroxymethyl)-36-(1H-indol-3-ylmethyl)-24-(2-methylsulfanylethyl)-2,8,11,14,17,20,23,26,29,32,35,38,41,44,52,55,58-heptadecaoxo-15,56-di(propan-2-yl)-47,48-dithia-1,7,10,13,16,19,22,25,28,31,34,37,40,43,51,54,57-heptadecazatricyclo[57.3.0.03,7]dohexacontan-45-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

2.1.2 InChI

InChI=1S/C132H217N45O33S3/c1-11-69(6)103(126(208)164-79(33-17-20-49-133)109(191)156-77(105(139)187)36-23-52-148-129(140)141)174-122(204)93-66-213-212-65-92(170-112(194)80(34-18-21-50-134)165-127(209)104(71(8)179)175-106(188)70(7)154-108(190)84(155-72(9)180)44-47-100(185)186)121(203)166-88(59-73-29-13-12-14-30-73)117(199)160-86(43-46-97(137)182)114(196)167-89(60-74-62-152-76-32-16-15-31-75(74)76)118(200)161-85(42-45-96(136)181)113(195)158-83(39-26-55-151-132(146)147)111(193)168-90(61-98(138)183)119(201)162-87(48-58-211-10)115(197)159-82(38-25-54-150-131(144)145)110(192)157-81(35-19-22-51-135)116(198)172-101(67(2)3)124(206)163-78(37-24-53-149-130(142)143)107(189)153-63-99(184)176-56-28-41-95(176)128(210)177-57-27-40-94(177)123(205)173-102(68(4)5)125(207)169-91(64-178)120(202)171-93/h12-16,29-32,62,67-71,77-95,101-104,152,178-179H,11,17-28,33-61,63-66,133-135H2,1-10H3,(H2,136,181)(H2,137,182)(H2,138,183)(H2,139,187)(H,153,189)(H,154,190)(H,155,180)(H,156,191)(H,157,192)(H,158,195)(H,159,197)(H,160,199)(H,161,200)(H,162,201)(H,163,206)(H,164,208)(H,165,209)(H,166,203)(H,167,196)(H,168,193)(H,169,207)(H,170,194)(H,171,202)(H,172,198)(H,173,205)(H,174,204)(H,175,188)(H,185,186)(H4,140,141,148)(H4,142,143,149)(H4,144,145,150)(H4,146,147,151)/t69-,70-,71+,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,101-,102-,103-,104-/m0/s1

2.1.3 InChI Key

RGOYAPXMTXPMMR-VCYGAANBSA-N

2.1.4 Canonical SMILES

CCC(C)C(C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)C)CCCNC(=N)N)C(C)C)CCCCN)CCCNC(=N)N)CCSC)CC(=O)N)CCCNC(=N)N)CCC(=O)N)CC4=CNC5=CC=CC=C54)CCC(=O)N)CC6=CC=CC=C6)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C

2.1.5 Isomeric SMILES

CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N2CCC[C@H]2C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)C(C)C)CCCNC(=N)N)C(C)C)CCCCN)CCCNC(=N)N)CCSC)CC(=O)N)CCCNC(=N)N)CCC(=O)N)CC4=CNC5=CC=CC=C54)CCC(=O)N)CC6=CC=CC=C6)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)C

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Ensereptide [inn]

2. Unii-smv73kw49c

3. Smv73kw49c

4. Acetyl(human Lactotransferrin-(15-39)-peptidamide)

5. Chembl1213249

6. 254433-51-7

2.3 Create Date

2011-02-17

3 Chemical and Physical Properties

Molecular Formula	C₁₃₂H₂₁₇N₄₅O₃₃S₃
Molecular Weight	3058.6 g/mol
XLogP3	-11.8
Hydrogen Bond Donor Count	46
Hydrogen Bond Acceptor Count	43
Rotatable Bond Count	72
Exact Mass	3057.5881129 g/mol
Monoisotopic Mass	3056.5847581 g/mol
Topological Polar Surface Area	1380 Å²
Heavy Atom Count	213
Formal Charge	0
Complexity	6930
Isotope Atom Count	0
Defined Atom Stereocenter Count	26
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1